Parker Schabel currently serves as the Global Treasurer at TOLMAR Inc., where he leverages his extensive expertise in healthcare strategy and finance to drive the company's capital allocation decisions. With a robust background in private equity investment and operational roles across healthcare and life sciences,...
Parker Schabel currently serves as the Global Treasurer at TOLMAR Inc., where he leverages his extensive expertise in healthcare strategy and finance to drive the company's capital allocation decisions. With a robust background in private equity investment and operational roles across healthcare and life sciences, Parker plays a pivotal role in aligning financial strategies with the company's overarching goals. His focus is on optimizing the allocation of capital to not only meet shareholder expectations but also to foster innovation through the development of new products and the expansion of TOLMAR's existing portfolio.
In his current role, Parker oversees key projects that involve rigorous financial analysis and competitive assessments, ensuring that each investment aligns with TOLMAR's strategic vision. His previous experience as Sr. Director of Finance (Business Development) and Director of Strategy and Planning has equipped him with a comprehensive understanding of market dynamics and operational efficiencies. During his tenure, he has successfully closed nine deals with an aggregate value exceeding $300 million, showcasing his adeptness in navigating complex financial landscapes from due diligence to legal execution.
Parker’s proficiency in corporate development and strategy is complemented by his ability to foster relationships with stakeholders across various sectors, including pharmaceuticals and healthcare IT. His strategic insights not only enhance TOLMAR's market position but also contribute to the sustainable growth of the organization, making him a key player in the healthcare investment landscape. As he continues to drive financial initiatives at TOLMAR, Parker remains committed to leveraging his skills in financial analysis and private equity to create lasting value for shareholders and improve patient outcomes.
